Form 4: Revvity Inc. Executive Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Revvity Inc. executive Prahlad R. Singh sold a portion of his holdings in company stock, including shares acquired through option exercises, under a pre-arranged 10b5-1 trading plan.
Summary
- Prahlad R. Singh, a director and officer at Revvity Inc., executed multiple transactions involving the company's common stock on December 2, 2024.
- These transactions included the acquisition of 18,365 shares through the exercise of stock options at a price of $81.29 per share.
- Singh also sold 15,088 shares at a weighted average price of $116.13 and 3,277 shares at a weighted average price of $116.63.
- The sales were conducted under a pre-arranged 10b5-1 trading plan adopted on August 1, 2024.
- Following these transactions, Singh directly owns 90,195 shares and indirectly owns 37,163 shares through the Singh Family Trust of 2021.
Sentiment
Score: 5
Explanation: The document reflects routine insider transactions under a pre-arranged plan, which is neither particularly positive nor negative. The sentiment is neutral.
Risks
- Executive stock sales can sometimes be perceived negatively by the market, potentially impacting investor sentiment.
Management Comments
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 1, 2024.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies, and the use of 10b5-1 plans is a standard practice for insiders to avoid accusations of trading on non-public information.
Comparison to Industry Standards
- The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the biotechnology and life sciences sectors, such as Thermo Fisher Scientific and Danaher Corporation.
- The reported sale prices of $116.13 and $116.63 are within the typical range for stock transactions of this nature, and the volume of shares sold is not unusual for an executive exercising options and selling shares.
Stakeholder Impact
- The transactions may have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan suggests the sales were pre-planned and not based on any new information.
Key Dates
| Date | Description |
|---|---|
| 01/30/2019 | First anniversary of the date on which the option was granted, and the date the option became exercisable in three equal annual installments. |
| 08/01/2024 | Date the 10b5-1 trading plan was adopted by the reporting person. |
| 12/02/2024 | Date of the stock option exercise and share sales. |
| 12/03/2024 | Date of the signature on the Form 4 filing. |
| 01/30/2025 | Expiration date of the NQ Stock Option. |
Keywords
Revvity Inc., insider trading, stock options, 10b5-1 plan, executive stock sales, Prahlad R. Singh, share transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.